Buy or sell Verge Genomics stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Verge Genomics Stock
Drug Discovery
About Verge Genomics Stock
Verge Genomics transforms drug discovery with artificial intelligence. Verge was founded by a unique combination of the field's top machine learning experts and seasoned neuroscience drug developers. Together, they share the vision that exponential advances in computational genomics combined with new insights into neuroscience has created a breakthrough opportunity to discover drugs that dramatically improve the lives of patients suffering from neurodegenerative disease.
Investors
ALS Investment Fund
Basis Set Ventures
Draper Associates
Thumbtack, Webflow, Standard Cognition, Tempo Automation, Goldbelly, Aerospike, Samba TV, Indiegogo, Verge Genomics, CryptoMove
Great Oaks Venture Capital
Bolt Financial, Workrise, Collective Health, Acorns, Course Hero, SingleStore, Virta Health, Human Interest, Maven Clinic, Petal
LifeForce Capital
Cityblock Health, HeartFlow, One Medical, Clover Health, Grand Rounds Health, Vineti, Verge Genomics
OS Fund
Pivot Bio, Emulate, Tempo Automation, Human Longevity, Verge Genomics, Elysium Health, uBiome, 3T Biosciences
Threshold
Zymergen, BetterUp, Talkdesk, Remitly, Divvy Homes, Prosper Marketplace, CircleCI, Viz, d.light design, Mythic
WuXi AppTec
Funding History
| June 2018 | $370K |
|---|---|
| June 2018 | $150K |
| June 2018 | $100K |
| June 2018 | $3.4M |
| June 2018 | $4.5M |
| June 2018 | $28.2M |
Management
Co-Founder & Chief Executive Officer
Alice Zhang
Chief Business Officer
Jane Rhodes
Press
PR Newswire - Jun, 27 2020
LegalReader - Apr, 22 2020
FierceBiotech - Jul, 16 2018
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
